The Dial Corporation

Quick facts

Phase 2 pipeline

• 3804-250A · Dermatology
  This drug is a topical antiseptic used to treat minor cuts and scrapes.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• The Dial Corporation portfolio CI brief
• The Dial Corporation pipeline updates RSS